| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | lactamide | 20 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 29 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 35 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 40 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 41 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 48 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 49 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 49 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 51 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 62 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 65 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 69 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 77 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | lactamide | 95 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 104 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 119 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 122 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 150 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 172 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 202 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 268 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 376 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 437 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 440 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 452 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | lactamide | 551 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 604 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 622 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 625 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 652 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 761 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 773 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | lactamide | 775 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 911 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1004 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1394 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1525 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1679 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1703 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 1867 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 1880 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 2180 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 2802 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | lactamide | 3013 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 3519 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 4787 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 4881 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 5282 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 5441 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | lactamide | 6263 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | lactamide | 7380 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 7454 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 7820 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | lactamide | 11786 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|